| Name | Title | Contact Details |
|---|---|---|
Lindsay Wills |
Associate General Counsel | Profile |
Rebecca Jewell |
Associate General Counsel, Neurology | Profile |
Avril McKean Dieser |
Head Global Neurology, Global Legal Affairs | Profile |
Denelle Waynick |
Vice President, Legal Affairs (US), US General Counsel and Global Enterprise Risk Management | Profile |
Deb Hogerman |
Vice President, Head of Global Regulatory Affairs | Profile |
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients by tackling key mechanisms of drug resistance that limit the effectiveness of many cancer therapies. Our small molecule drug candidates are directed against an important family of enzymes called kinases, known to be directly involved in the growth and spread of many cancers. We use our deep understanding of kinase biology together with a proprietary chemistry library to purposefully design compounds that maintain kinases in a “switched off” or inactivated conformation. Deciphera has developed a diverse pipeline of drug candidates designed to improve outcomes for patients with cancer by enhancing the quality, rate and/or durability of their responses to treatment.
Dynarex Corporation is a Orangeburg, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
iTherX is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Emcure Pharmaceuticals, headquartered at Pune in West India, is an Indian pharmaceutical company.
Emendo biotherapeutics develops next generation gene editing tools for genetic disorders, addressing the current technological gaps for realizing the promise of gene therapy.